CARCINOMA, ADRENAL CORTICAL
Clinical trials for CARCINOMA, ADRENAL CORTICAL explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, ADRENAL CORTICAL trials appear
Sign up with your email to follow new studies for CARCINOMA, ADRENAL CORTICAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancer: radiation before surgery trial seeks to stop recurrence
Disease control Recruiting nowThis study is testing if giving targeted radiation therapy before surgery is safe and can help control a rare and aggressive adrenal gland cancer that has come back after initial treatment. It will enroll up to 32 adults whose recurrent cancer can still be surgically removed. The…
Matched conditions: CARCINOMA, ADRENAL CORTICAL
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
First patients sought for groundbreaking trial targeting rare, aggressive cancers
Disease control Recruiting nowThis is the first-ever study in people for a new drug called ADCT-701, designed for adults with rare and hard-to-treat cancers like neuroendocrine tumors and malignant peripheral nerve sheath tumors. The main goal is to find the safest and most effective dose by giving the drug t…
Matched conditions: CARCINOMA, ADRENAL CORTICAL
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC